CID 3070373

86384-20-5

Structural Information

Molecular Formula
C16H32N9O2P3
SMILES
C1CN1[P@]2(=NP(=NP(=N2)(N3CC3)N4CC4)(N5CC5)N6CCOCC6)N7CCOCC7
InChI
InChI=1S/C16H32N9O2P3/c1-2-20(1)28(21-3-4-21)17-29(22-5-6-22,24-9-13-26-14-10-24)19-30(18-28,23-7-8-23)25-11-15-27-16-12-25/h1-16H2/t29-,30?/m0/s1
InChIKey
XIJWTPCVDLXZPZ-UFXYQILXSA-N
Compound name
4-[(2R)-2,4,4,6-tetrakis(aziridin-1-yl)-6-morpholin-4-yl-1,3,5-triaza-2lambda5,4lambda5,6lambda5-triphosphacyclohexa-1,3,5-trien-2-yl]morpholine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

4
Patents

475.18918 Da
Monoisotopic Mass

0.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 476.19646 253.2
[M+Na]+ 498.17840 248.7
[M-H]- 474.18190 252.8
[M+NH4]+ 493.22300 240.2
[M+K]+ 514.15234 254.8
[M+H-H2O]+ 458.18644 243.7
[M+HCOO]- 520.18738 256.5
[M+CH3COO]- 534.20303 246.7
[M+Na-2H]- 496.16385 237.7
[M]+ 475.18863 249.9
[M]- 475.18973 249.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe